Holly E. Humphries

Porton, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 15 publications

Persistence of the immune response after two doses of ChAdOx1 nCov-19 (AZD1222): 1 year of follow-up of two randomized controlled trials.

Persistence of the immune response after two doses of ChAdOx1 nCov-19 (AZD1222): 1 year of follow-up of two randomized controlled trials.

Journal: Clinical and experimental immunology

Published: November 01, 2022

Generation of a Universal Human Complement Source by Large-Scale Depletion of IgG and IgM from Pooled Human Plasma.

Generation of a Universal Human Complement Source by Large-Scale Depletion of IgG and IgM from Pooled Human Plasma.

Journal: Methods in molecular biology (Clifton, N.J.)

Published: November 16, 2021

Influence of Aerosol Delivered BCG Vaccination on Immunological and Disease Parameters Following SARS-CoV-2 Challenge in Rhesus Macaques.

Influence of Aerosol Delivered BCG Vaccination on Immunological and Disease Parameters Following SARS-CoV-2 Challenge in Rhesus Macaques.

Journal: Frontiers in immunology

Published: October 25, 2021

Immunological and pathological outcomes of SARS-CoV-2 challenge following formalin-inactivated vaccine in ferrets and rhesus macaques.

Immunological and pathological outcomes of SARS-CoV-2 challenge following formalin-inactivated vaccine in ferrets and rhesus macaques.

Journal: Science advances

Published: September 13, 2021

Correlates of protection against symptomatic and asymptomatic SARS-CoV-2 infection.

Correlates of protection against symptomatic and asymptomatic SARS-CoV-2 infection.

Journal: Nature medicine

Published: June 21, 2021

One or two dose regimen of the SARS-CoV-2 synthetic DNA vaccine INO-4800 protects against respiratory tract disease burden in nonhuman primate challenge model.

One or two dose regimen of the SARS-CoV-2 synthetic DNA vaccine INO-4800 protects against respiratory tract disease burden in nonhuman primate challenge model.

Journal: Vaccine

Published: April 16, 2021

ChAdOx1 nCoV-19 protection against SARS-CoV-2 in rhesus macaque and ferret challenge models.

ChAdOx1 nCoV-19 protection against SARS-CoV-2 in rhesus macaque and ferret challenge models.

Journal: Communications biology

Published: March 29, 2021

Reduced neutralization of SARS-CoV-2 B.1.1.7 variant by convalescent and vaccine sera.

Reduced neutralization of SARS-CoV-2 B.1.1.7 variant by convalescent and vaccine sera.

Journal: Cell

Published: January 29, 2021

Quantification of SARS-CoV-2 neutralizing antibody by wild-type plaque reduction neutralization, microneutralization and pseudotyped virus neutralization assays.

Quantification of SARS-CoV-2 neutralizing antibody by wild-type plaque reduction neutralization, microneutralization and pseudotyped virus neutralization assays.

Journal: Nature protocols

Published: December 07, 2020

A recombinant commensal bacteria elicits heterologous antigen-specific immune responses during pharyngeal carriage.

A recombinant commensal bacteria elicits heterologous antigen-specific immune responses during pharyngeal carriage.

Journal: Science translational medicine

Published: September 18, 2020

Comparison of rhesus and cynomolgus macaques as an infection model for COVID-19.

Comparison of rhesus and cynomolgus macaques as an infection model for COVID-19.

Journal: Nature communications

Published: September 06, 2020

Dose-dependent response to infection with SARS-CoV-2 in the ferret model and evidence of protective immunity.

Dose-dependent response to infection with SARS-CoV-2 in the ferret model and evidence of protective immunity.

Journal: Nature communications

Published: May 23, 2020

Showing 1-12 of 15

Last Updated: 09/26/2026